Concepedia

Erkan Baloglu

EB

Statistics

Publications

59

Citations

4.6K

H-Index

36

Active since

1999

Affiliations

Karyopharm Therapeutics (United States)(Current)

Wayne State University

National University of Singapore

University of California, Los Angeles

National University Cancer Institute, Singapore

Erkan Baloglu is an author at Karyopharm Therapeutics (United States) specializing in oncology, molecular oncology, and medicine.

Publications per year

1999–2023

59

Publications

59

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

Mercedes Lobera, Kevin P. Madauss, Denise Teotico Pohlhaus et al. · Nature Chemical Biology · 2013 · 375 citations

Life Sciences, Biochemistry, Molecular Biology +12

The Taxane Diterpenoids

Erkan Baloglu, David G. I. Kingston · Journal of Natural Products · 1999 · 310 citations

Life Sciences, Biochemistry, Plant Sciences +12

Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms

Sheng Xiao, Nir Yosef, Jianfei Yang et al. · Immunity · 2014 · 280 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma

Yan-Yi Jiang, De‐Chen Lin, Anand Mayakonda et al. · Gut · 2016 · 235 citations · Full text

Medicine, Oncology, Pharmacology +16

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

Jimi Kim, Elizabeth A. McMillan, Hyun Seok Kim et al. · Nature · 2016 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 59